Castañeda-Hernández G - Search Results

1

Use of pharmacogenomics in pediatric renal transplant recipients.

Medeiros M, Castañeda-Hernández G, Ross CJ, Carleton BC. Medeiros M, et al. Front Genet. 2015 Feb 18;6:41. doi: 10.3389/fgene.2015.00041. eCollection 2015. Front Genet. 2015. PMID: 25741362 Free PMC article. Review.

2

Bioavailability of two oral formulations of cyclosporin A in uremic children before renal transplantation.

Medeiros M, Gómez AC, Urizar JP, Campos-Sepúlveda AE, Saldaña IM, Ramírez LE, Romero NB, Velásquez JL, Castañeda-Hernández G, Muñoz R. Medeiros M, et al. Pediatr Transplant. 1998 May;2(2):145-9. Pediatr Transplant. 1998. PMID: 10082447 Clinical Trial.

3

Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune or Neoral cyclosporin A oral formulations.

Medeiros M, Pérez-Urizar J, Muñoz R, Castañeda-Hernández G. Medeiros M, et al. Pediatr Transplant. 1999 Aug;3(3):225-30. doi: 10.1034/j.1399-3046.1999.00037.x. Pediatr Transplant. 1999. PMID: 10487284 Clinical Trial.

4

Decreased cyclosporine exposure during the remission of nephrotic syndrome.

Medeiros M, Pérez-Urizar J, Mejía-Gaviria N, Ramírez-López E, Castañeda-Hernández G, Muñoz R. Medeiros M, et al. Pediatr Nephrol. 2007 Jan;22(1):84-90. doi: 10.1007/s00467-006-0300-6. Epub 2006 Oct 20. Pediatr Nephrol. 2007. PMID: 17053886 Clinical Trial.

5

Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.

Medeiros M, Pérez-Urizar J, Pedraza-Chaverri J, Muñoz-Arizpe R, Castañeda-Hernández G. Medeiros M, et al. Can J Physiol Pharmacol. 2007 May;85(5):502-6. doi: 10.1139/y07-025. Can J Physiol Pharmacol. 2007. PMID: 17632584

6

Comparison of dissolution properties of 2 enteric-coated formulations containing mycophenolate sodium: Myfortic vs Femulan.

Esquivel A, González-Ramírez R, Alberú J, Gracida C, Medeiros M, Castañeda-Hernández G. Esquivel A, et al. Transplant Proc. 2010 Jan-Feb;42(1):353-6. doi: 10.1016/j.transproceed.2009.11.015. Transplant Proc. 2010. PMID: 20172348

7

Efficacy and safety of conversion of mycophenolate mofetil to enteric-coated mycophenolate sodium in Mexican renal transplant children.

Reyes H, Hernández AM, Valverde S, Cataneo A, Mendoza A, Barrera I, Ortíz L, García-Roca P, Lopéz-Martínez B, Castañeda-Hernández G, Medeiros M. Reyes H, et al. Pediatr Transplant. 2010 Sep 1;14(6):746-52. doi: 10.1111/j.1399-3046.2010.01326.x. Epub 2010 Apr 13. Pediatr Transplant. 2010. PMID: 20412508

8

Pre-transplant mycophenolate mofetil pharmacokinetics in Mexican children.

Villa M, González R, García-Roca P, Hernández AM, Ortiz L, Castañeda-Hernández G, Medeiros M. Villa M, et al. Proc West Pharmacol Soc. 2011;54:66-8. Proc West Pharmacol Soc. 2011. PMID: 22423584

9

CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing.

García-Roca P, Medeiros M, Reyes H, Rodríguez-Espino BA, Alberú J, Ortiz L, Vásquez-Perdomo M, Elizondo G, Morales-Buenrostro LE, Mancilla Urrea E, Castañeda-Hernández G. García-Roca P, et al. Arch Med Res. 2012 May;43(4):283-7. doi: 10.1016/j.arcmed.2012.05.005. Epub 2012 Jun 13. Arch Med Res. 2012. PMID: 22704849

10

[Intimidation against renal transplantation scientist].

Esquivel A, González R, Alberú J, Gracida C, Medeiros M, Castañeda-Hernández G. Esquivel A, et al. Rev Invest Clin. 2012 May-Jun;64(3):215-9. Rev Invest Clin. 2012. PMID: 23045942 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters